Your browser doesn't support javascript.
loading
Immunogenicity and safety of mixed COVID-19 vaccine regimens in patients with immune-mediated inflammatory diseases: a single-centre prospective cohort study.
Hitchon, Carol A; Mesa, Christine; Bernstein, Charles N; Marrie, Ruth Ann; Card, Catherine; O'Brien, Sheila F; Kim, John.
Afiliação
  • Hitchon CA; Internal Medicine, University of Manitoba, Winnipeg, Manitoba, Canada carol.hitchon@umanitoba.ca.
  • Mesa C; National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada.
  • Bernstein CN; Internal Medicine, University of Manitoba, Winnipeg, Manitoba, Canada.
  • Marrie RA; Internal Medicine, University of Manitoba, Winnipeg, Manitoba, Canada.
  • Card C; Community Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada.
  • O'Brien SF; National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada.
  • Kim J; Medical Microbiology and Infectious Diseases, University of Manitoba, Winnipeg, Manitoba, Canada.
BMJ Open ; 13(5): e071397, 2023 05 30.
Article em En | MEDLINE | ID: mdl-37253487

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Artrite Reumatoide / COVID-19 Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Artrite Reumatoide / COVID-19 Idioma: En Ano de publicação: 2023 Tipo de documento: Article